Introduction

!
An unusually high number of nosocomial as well as community-acquired respiratory syncytial virus (RSV) infections of the respiratory tract in adult patients particularly with a hematological or autoimmune primary disease was seen in the winter of 2011/2012 at a hematology and transplant center [1, 2] . RSV infection is known primarily as an inflammatory change of the lung in children. This pathogenic agent has been less frequently described as a communityacquired infection in adults. RSV pneumonia is more frequently seen in patients who have undergone stem cell transplantation and have a malignant hematological primary disease or in the case of immunosuppression [3 -5] . Mild to moderate inflammation of the upper respiratory tract is typical in immunocompetent adults. However, in immunosuppressed or older patients with preexisting conditions, an RSV infection can result in severe pneumonia with a fatal outcome in some cases. Therefore, it is important for the radiologist to know the immune status of the patient being examined [6] . The RS virus is a pneumovirus and is part of the paramyxoviridae family. The mumps virus and parainfluenza virus also belong to the paramyxoviridae family. RSV is an enveloped virus with negative single-strand RNA. It can be differentiated into subtypes A and B. RSV is transmitted primarily via smear infection. It can live on surfaces for several hours and be incorporated by large drops or droplet infection. Therefore, hands should be disinfected and masks should be worn for primary prevention. Initial infection with RSV usually occurs in children. Due to incomplete immunity, reinfection often occurs but has a milder clinical course. The following clinical symptoms are seen in decreasing order of frequency: rhinorrhea, whistling respiratory sound, dyspnea, productive coughing, fever, and myalgia. RSV replicates in the ciliated epithelial cells of the mucous membranes of the respiratory tract. The infection can last from 6 days to 8 weeks. There are four established diagnostic procedures for detecting RSV including virus culture, antigen determination via immunofluorescence assay (IFA) or enzyme immunoassay (EIA), RNA determination via RT-PCR (real-time polymerase chain reaction) and serology. With 60 -90 % PCR has the highest sensitivity. Adult patients are typically treated based on symptoms. A bacterial superinfection that complicates the course of the RSV infection occurs in 10 -30 % of cases. It was shown in vitro that a superinfection in the case of an existing RSV infection is most frequently associated with Haemophilus influenzae and Streptococcus pneumoniae [7] . Ribavirin is a broad-spectrum antiviral medication with a controversial therapeutic effect. It is used in children and older patients. There is currently no approved RSV vaccine [6] . The CT-morphological signs of RSV pneumonia are not frequently described in the current literature and are often underdiagnosed or misinterpreted in the clinical routine, e. g. due to similar morphologies confused with fungal infections [8] . Fungal infections, primarily Aspergillus infections, are a complication with a potentially fatal outcome in patients with malignant hematological diseases or immunosuppression. Therefore, diagnosis (microbiology and primarily computed tomography) plays a major role in differentiation and treatment planning [9] . The goal of this analysis is to identify characteristic morphologies in chest CT in patients with RSV pneumonia in order to make CT-morphological diagnosis of RSV pneumonia more probable.
Materials and Methods
!
All patients of medical clinic V between November 2011 and July 2012 who tested RSV-positive and underwent a chest CT (median 1 day after [30 days before, 19 days after] a positive test) were included in the retrospective analysis approved by the ethics commission. The significant variability was the result of the fact that the epidemic (November 2011) was initially not recognized as such and thus serial RSV testing was not performed until December 2011. The first chest CT in each case was performed within the first 24 hours after the start of clinical symptoms. Samples were acquired via throat swab (n = 447), sputum (n = 7), tracheal secretion (n-14), or bronchoalveolar lavage (BAL) (n = 62) and examined via PCR [10] . The tests were thus performed in all patients several times with different sample materials and analysis techniques over the course of the disease. Bronchoalveolar lavage was performed in patients (n = 20) who had already undergone chest CT showing pronounced radiological changes. The patients included in the study primarily had hematological and autoimmune primary diseases, e. g. multiple myeloma or acute myelocytic leukemia ( • " Table 1 ). The CT examinations of the thorax (n = 132) and in some cases also of the paranasal sinuses (n-19) were primarily performed using a 128-row iCT (Philips, Hamburg). In addi-(Bronchialwandverdickungen, tree-in-bud, Noduli, Halo, Milchglas, Konsolidierungen, Pleuraerguss) der radiologischen Bilder durch zwei erfahrene Thoraxradiologen tion, individual chest examinations were performed using other devices (Somatom Definition Flash, Sensation 16, Volume Zoom and Definition AS40, Siemens Medizintechnik, Forchheim). The technique was usually native (n = 106/132, with a slice thickness of 3 -5 mm (n = 124 with 3 mm, n = 5 with 4 mm, n = 3 with 5 mm) always in spiral technique during an inspiratory breath hold with dose modulation. The images were interpreted in consensus by two experienced chest radiologists on a PACS workstation (Synapse 3.2.1, Fujifilm, Düsseldorf) in accordance with DIN 6868 -57 with two category A monitors using all of the usual image viewing techniques. In the case of follow-up examinations, each examination was evaluated individually as well as in comparison to determine whether worsening or improvement could be detected. A visually noticeable increase in pathologies or the occurrence of new pathologies was evaluated as worsening of the findings. An improvement was defined as a visually detectable relevant decrease in pathologies. To evaluate characteristic early signs of RSV pneumonia, the particular CT was evaluated at the presumable start of the disease. Even patients without a follow-up examination were included. A further inclusion criterion was a low number of pathologies (fewer than two at the same time). Exclusion criteria were more than two simultaneously present pathologies or large-area changes (> 25 % of the lung parenchyma). A tabular schema based on the current literature was used for the qualitative and quantitative evaluation of the lung parenchyma [3] . Bronchial wall thickening, tree-in-bud, nodules, halo, ground-glass opacity, consolidations, and pleural effusions were evaluated with respect to their anatomical distribution (bi-/unilateral, basal/apical, central/peripheral, peribronchovascular/lobar/(non-)segmental/random) and if possible were quantified (longitudinal diameter and number (< 5, 5 -10, > 10) of nodules, percentage estimation of the proportion of ground-glass opacity or consolidations in relation to the total lung parenchyma, ventrodorsal diameter of the pleural effusions).
The individual lung parenchymal changes were preferentially defined according to the criteria of the "Fleischner Society's glossary of terms" [11] : Nodules of up to 3 cm were included and classified as consolidations. An increase in the density of the lung parenchyma with still recognizable vascular structures was defined as a ground-glass change. Consolidations were then documented when increases in the lung parenchyma density did not have recognizable vascular structures. These were then additionally differentiated as respiratory tract consolidations and parenchyma consolidations. In individual patients (19/51), the skull was examined via CT or MRI for neuroradiological purposes. These images were only used in the present analysis to evaluate the paranasal sinuses. Air-fluid levels in the individual paranasal sinuses were evaluated as acute sinusitis. If this was found in all sinuses, pansinusitis was diagnosed. Any osseous arrosion was noted.
Results
!
The main scan period of the patients in this evaluation was from December 2011 to March 2012. 51 patients with a positive RSV test were examined in a total of 132 chest CT examinations. 6 additional patients had a positive RSV test but only had minor clinical symptoms so that no radiological imaging was performed. Therefore, these 6 patients were not included in the present study. The average age was 58 years. 75 % of the patients were examined multiple times. A pathological lung finding in terms of the study evaluation was found in 86 % of the examined patients. As a result, 14 % of the patients had a normal finding in this regard despite clinical symptoms of pneumonia. 55 % of the patients required oxygen and 29 % required intensive care and ventilation. 27 % of the patients suffered an infection-associated death ( • " Table 2 ). 14 % of the patients did not show any pathology on the chest CT scans despite clinical symptoms of pneumonia. 28 of the 132 CT scans were performed in these patients. All of these CT scans were reconstructed with a slice thickness of 3 mm. 4 of these patients underwent a single examination. Two patients underwent one follow-up examination and one patient underwent three follow-up examinations. The average age of these patients was also 58 years (from 24 to 76 years) Chestand the primary diseases also varied. All of these CT scans did not show any pathological change, also not over the course of the disease, i. e., these patients were RSV-positive and had clinical symptoms of pneumonia but lung parenchymal changes were not seen over the entire period. In general, the following pathological CT changes were seen in descending order of frequency: ground-glass opacity (95 % bilateral, average 18 % of the lung parenchyma), consolidations (average 11 % of the lung parenchyma, 23 % with positive bronchoaerogram), nodules, tree-in-bud, bronchial wall thickening ( • " Table 3 ). These pathologies were associated with pleural effusions (average 2 cm) in 63 % of the patients. Nodules with an average maximum diameter of 8 mm (from 3 to 25 mm) typically occurred in high numbers (14 %, < 5, 13 % 5 -10, 74 % > 10 nodules) and in a centrilobular position (58 %) (often also random (29 %)) and had a halo in 81 % of the patients ( • " Table 3 , • " Fig. 1 ). Multiple radiomorphological lung parenchymal changes with the following distribution in the lung parenchyma in descending order were detected in 72 % of all CT examinations: 30 % random, 22 % segmental, 22 % basal, 12 % apical, and 12 % lobar. In addition to the positive RSV test, HSV (herpes simplex virus) was found in BAL in two cases and HSV as well as Aspergillus spec. in an additional two cases. Pseudomonas aeruginosa was found in BAL immediately prior to death in one case. Thus, a second pathogenic agent was found in 5/51 (10 %) patients. Two or more CT examinations were performed in the course of the disease in 38/51 (75 %) patients, thus making it possible to evaluate the radiomorphological development of the RSV pneumonia in a relevant patient collective. The median time between the first and second follow-up examination was 11 days. With 79 % (30/38) ground-glass opacity was the most common pathological sign on the first CT scan of patients with later follow-up examinations ( • " Fig. 2 ). With 61 %, nodules were the second most common pathological sign ( • " Fig. 3 ). With 87 % nodules were the most frequent pathological sign in the first follow-up examination and with 65 % ground-glass opacity was the second. To evaluate the characteristic early changes of RSV pneumonia, the relevant CT scan was assessed at the presumed start of the disease. However, as already described above, the positive RSV test varied with respect to time since the epidemic was not initially recognized as such. 34/51 (67 %) patients were evaluated in this regard. Nodules were found in 53 % (18/34) of patients, bronchial wall thickness in 41 % (14/34), tree-in-bud pattern in 32 % (11/34), pleural effusions in 21 % (7/34), ground-glass opacity only in 3 % (1/ 34) and consolidations in no patients. It is noteworthy that bronchial wall thickening occurred in combination with nodules or the tree-in-bud pattern in 79 % (11/14) of the cases.
An exemplary but very typical image is shown in • " Fig. 1 . The median time between CT examinations with progression of the findings was 7 days and 22 days in the case of regression of the findings. A radiological increase in findings was diagnosed in 45 % of patients ( • " Fig. 3b-d) , regression in 33 % ( • " Fig. 3e ) and no significant change in the findings in the remaining 22 % in the follow-up examinations. The groundglass opacity increased by 21 % and the consolidations by 12 % in the examinations with progression of the findings. New nodules and the tree-in-bud pattern occurred in 22 % of the cases ( • " Fig. 4 ).
The paranasal sinuses were evaluated via CT or MRI in 37 % (19/51) of the patients. In 63 % (12/19) of these examinations, air-fluid levels and thus sinusitis were able to be diagnosed. All paranasal sinuses were affected in 26 % (5/19) of the cases, i. e. pansinusitis was diagnosed. In addition to these findings, further intracranial pathologies (otitis media (2 cases), mastoiditis (4 cases), subdural hematoma (3 cases), subdural hygroma (1 case)) were found in 42 % (8/19) of the patients but no osseous arrosions were found. 90 % (11/12) of the patients with sinusitis or pansinusitis also had pneumonic lung infiltrates and 50 % (6/12) required ventilation.
Discussion
!
The seasonal occurrence of RSV infections is known and is also reflected in the main scan period of the patients in this analysis [3, 5] . Compared to other studies, this study is the first to address the CT-morphological changes of RSV pneumonias over the course of the disease and to additionally analyze its association with sinusitis. 51 patients and 132 chest CT examinations were included. In these CT examinations ground-glass opacity was found most frequently with a rate of 64 %, followed by consolidations with 56 %, and nodules with 50 % (in 74 % > 10). The most common pathological morphologies in patients with a follow-up examination were ground-glass opacity and nodules (primarily centrilobular) in this order of frequency. This was reversed in the first follow-up examination and nodules were seen more frequently than ground-glass opacity. The other detected pathologies were rarer. The clinical spectrum ranged from mild clinical infection constellation to intensive care with organ failure [12] . The above range of pulmonary changes as seen for example in H3N2 influenza infections generally supports the diagnosis of viral pneumonia. However, the occurrence of multiple pulmonary changes is only suggestive but not specific for viral pneumonia as in H3N2, for example [13] . Other studies that have addressed CT changes in immunosuppressed patients with RSV pneumonia obtained similar results:
The three most common pathological signs in descending order of frequency according to Franquet et al. were groundglass opacity, nodules, and bronchial wall thickening. Of 130 patients who underwent hematopoietic stem cell transplantation, BAL, and chest CT, 26 patients with proven RSV pneumonia were included in this retrospective evaluation [3] . In a study by Gasparetto et al., 20 bone marrow transplant patients with nosocomial RSV pneumonia underwent CT examination within 24 hours of the start of symptoms. RSV was diagnosed via BAL, nasopharyngeal swab, or nasal lavage. Nodules, consolidations, and ground-glass opacity were found in this order of frequency [4]. Escuissato et al. included 111 bone marrow transplant recipients from a cohort of 774 patients who underwent chest CT within 24 hours of the start of symptoms. All of these patients had symptoms of pneumonia. However, RSV pneumonia was verified in only 30 patients. Primarily nodules, consolidations, and ground-glass opacity were found in patients with RSV pneumonia in this study [14] .
Miller et. al [15] who retrospectively examined the CT-morphological characteristics of 115 community-acquired bacterial and viral (19 RSV) infections of the lower respiratory tract found the tree-in-bud pattern and bronchial wall thickening most frequently in association with RSV.
It should be mentioned that there were only a limited number of RSV-positive patients with no pathological changes in the CT examinations despite symptoms of pneumonia. In contrast, the percentage of such cases was 14 % in the study by Ko et al. [16] and in the present study and 20 % in the studies by Escuissato et al. [14] and Gasparetto et al. [4] . All negative CT scans in the present study were reconstructed with a slice thickness of 3 mm. It is therefore not assumed that significant findings were overlooked but rather that these CT scans in fact did not show any pathologies.
In light of the fact that nodules were the second most frequent finding with a rate of 50 % in this analysis and 70 % of these had a halo, it is useful to point out that this halo is a non-specific morphological change that can be caused by a hemorrhage or local infiltration. However, the halo sign is often found in association with a pulmonary fungal infection [11, 17] . Fungal infections, primarily Aspergillus infections, are a complication with a potentially fatal outcome in patients with malignant hematological diseases or immunosuppression. Therefore, diagnosis (microbiology, computed tomography) plays a major role in differentiation and treatment planning [9] . The current evaluation analyzes both the morphological criteria in each CT scan and the course of the disease with respect to progression or regression. The following parameters were taken into consideration: which change could be detected from the beginning, which new parenchymal patterns occurred, what was the extent of any new parenchymal patterns. The current literature includes a study by Ko et al. [16] who also used CT to examine the course of RSV pneumonias. The collective of 7 patients in this study included lung transplant recipients. However, the follow-up evaluation only relates to progression, regression, and stabilization. Concrete morphological changes are not described. It can be assumed that the course of RSV pneumonia includes different visible morphological stages. The most characteristic is the initial stage since many different parenchymal changes occur at the same time in the advanced stages. Nodules which are often seen in combination with bronchial wall thickening occur in the greatest numbers and have the most characteristic morphological appearance. The paranasal sinuses were also evaluated in 19 of the 51 analyzed patients (37 %) with a positive RSV test. Acute sinusitis or pansinusitis was diagnosed in 63 % of the patients and 90 % of these had clinical and radiological pneumonia. In viral rhinosinusitis, there is increased production of viscous material in the sinus that accumulates there since the regular removal process is impaired by disrupted and reduced cilia functionality [18] . This can facilitate a bacterial superinfection [18] . In addition, RSV plays different roles in the pathogenesis of the infection from colonization and incidental co-infection, which acts as the precursor to other pathogens, to possible major pathogens [19 -21] . RSV-associated sinusitis or pansinusitis is rarely described in the current literature [22, 23] . New literature addressing both the CTmorphological changes of RSV pneumonia and the presence of sinusitis also cannot be found. RSV sinusitis presumably arises from RSV pneumonia. Therefore, it would be useful to test the upper respiratory tract separately from the lower tract during pathogen diagnosis in order to be able to prove this in possible further studies.
This study has the following limitations: Firstly, it is a retrospective, descriptive analysis whose observed incidence was presumably increased during RSV screening and mild clinical processes that would not have been tested for RSV in a targeted manner under different circumstances were monitored. This allowed a broader radiological characterization of RSV pneumonia. Secondly, only chest CT scans with a slice thickness of 3 -5 mm were available for the evaluation. 1-mm slices were not available. It is possible that minor pathologies, such as ground-glass opacities, may not have been correctly evaluated or detected on the few CT scans with a slice thickness of 4 mm or 5 mm (n = 9). Thirdly, a superinfection was detected via BAL in 5/51 patients. However, not every patient underwent BAL and not every pathogenic agent detected via BAL causes pneumonia but in some cases only colonization without a pathogenic effect [20, 24, 25] . For example, an RSV infection of the respiratory tract was detected in a prospective study including 165 children on ventilation (median age 1.6 months old), 22 % of whom had a verified bacterial co-infection and another 21 % had a possible bacterial co-infection [19] . Fourthly, no special or systematic examination of the paranasal sinuses (e. g. nasopharyngeal lavage, nasal swab) was performed in patients with sinusitis since this issue was not the focus of the head examinations [23] .
Conclusion
!
This analysis of chest CT scans shows that ground-glass opacity, consolidations, and nodules with a halo were seen in cases of RSV pneumonia. Ground-glass opacity was primarily seen in the initial stage, while centrilobular nodules were seen in the advanced stages. In most cases, multiple pathological changes that developed primarily due to worsening of the symptoms were present at the same time. However, the chest CT scans acquired at the presumed start of the disease with nodules or tree-in-bud often in combination with bronchial wall thickening were most characteristic. Although these are not pathognomic lung parenchymal changes, they are characteristic so that RSV-associated pneumonia should be considered with greater frequency on a seasonal basis (winter months) and associated sinusitis should also be taken into consideration.
Relevance of the study ! 1. Characterization of pneumonia to identify indicators of possible triggers 2. Targeted use of suitable screening tests for pathogen identification 3. Early detection of RSV pneumonia for early treatment planning primarily in immunosuppressed patients 4. Prevention of unnecessarily broad and long-lasting empiric antibiotic regimens to lower costs, toxicity, and resistance development
